Tumor-associated antigens (TAAs) are proteins that are expressed by tumor cells and can be recognized by the immune system. TAAs can be used to develop cancer vaccines and immunotherapies. TAAs can be classified into several categories including differentiation antigens, cancer-testis antigens, overexpressed antigens, mutated antigens, and viral antigens.
Tumor-associated antigens
Canertinib dihydrochloride, Receptor protein-tyrosine kinase erbB-4 inhibitorCas#:289499-45-2
Starting at $35.90
- BMS202 (PD-1/PD-L1 inhibitor 2), Agonist of CB 1 receptor;Agonist of CB 2 receptor
Cas#:1675203-84-5
Starting at $31.90
- Erlotinib HCl (OSI-744), Epidermal growth factor receptor erbB1 inhibitor
Cas#:183319-69-9
Starting at $64.90
-
-
-
-
-
-
-
-
-
